SCHEMBL32665347

SCHEMBL32665347

c1ccc2c(c1)ccc1nc3c(ccc4cccnc43)cc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.58
LMNA P02545 4/20 0.56
CCR1 P32246 5/20 0.53
CCR8 P51685 5/20 0.53
MAPT P10636 5/20 0.53
KDM4E B2RXH2 4/20 0.53
CCR5 P51681 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
TDP1 Q9NUW8 3/20 0.53
HIF1A Q16665 2/20 0.53
TSHR P16473 2/20 0.53
GMNN O75496 1/20 0.53
TP53 P04637 1/20 0.53
HSP90AA1 P07900 1/20 0.53
MMP2 P08253 1/20 0.53
CYP2D6 P10635 1/20 0.53
MMP9 P14780 1/20 0.53
ALOX15 P16050 1/20 0.53
NFKB1 P19838 1/20 0.53
MMP8 P22894 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17422014 1.00 CYP3A4 (0.58) CYP3A4LMNACCR1CCR8MAPT
Phenanthroline SCHEMBL12989613 0.84 LMNA (0.54) CYP3A4LMNACCR1CCR8MAPT
Phenanthrene SCHEMBL16685315 0.84 CCR1 (0.76) CYP3A4LMNACCR1CCR8MAPT
SCHEMBL606941 0.82 ALDH1A1 (0.54) CYP3A4LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL30373850 0.82 ALDH1A1 (0.54) CYP3A4LMNAMAPTKDM4ESMN1; SMN2
SCHEMBL20211394 0.79 CCR1 (0.61) CYP3A4LMNACCR1CCR8MAPT
SCHEMBL5476360 0.79 CCR1 (0.61) CYP3A4LMNACCR1CCR8MAPT
1-Naphthoquinoline SCHEMBL28583281 0.78 LMNA (0.67) CYP3A4LMNACCR1CCR8MAPT
1-Naphthoquinoline SCHEMBL28190950 0.78 LMNA (0.67) CYP3A4LMNACCR1CCR8MAPT
SCHEMBL3193877 0.78 LMNA (0.67) CYP3A4LMNACCR1CCR8MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE CONWAY DAVID JONATHAN (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260022138-A1 METAL ORGANIC FRAMEWORKS FOR OLED APPLICATIONS AND METHODS OF USE TRPV3, VDR, TRPC3 CYP3A4 1596/4885LMNA 2552/4885CCR1 2771/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.